Literature DB >> 34843015

Determinants of high-density lipoprotein (HDL) functions beyond proteome in Asian Indians: exploring the fatty acid profile of HDL phospholipids.

Himani Thakkar1, Vinnyfred Vincent1, Ambuj Roy2, Ajay Kumar Gautam1, Rintu Kutum3, Lakshmy Ramakrishnan4, Sandeep Singh2, Archna Singh5.   

Abstract

Impaired high-density lipoprotein (HDL) functions are associated with development of coronary artery disease. In this study, we explored the quantitative differences in HDL (i.e. HDL proteome and fatty acid profile of HDL phospholipids) underlying the functional deficits associated with acute coronary syndrome (ACS). The relationship between HDL function and composition was assessed in 65 consecutive ACS patients and 40 healthy controls. Cholesterol efflux capacity (CEC) of HDL and lecithin cholesterol acyl transferase (LCAT) activity were significantly lower in patients with ACS compared to controls. In HDL proteome analysis, HDL isolated from ACS individuals was enriched in apolipoprotein C2 (inhibitor of LCAT), apolipoprotein C4 and serum amyloid A proteins and was deficient in apolipoprotein A-I and A-II. The fatty acid profile of HDL phospholipids analyzed using gas chromatography showed significantly lower percentages of stearic acid (17.4 ± 2.4 vs 15.8 ± 2.8, p = 0.004) and omega-3 fatty acids [eicosapentaenoic acid (1.0 (0.6-1.4) vs 0.7 (0.4-1.0), p = 0.009) and docosahexaenoic acid (1.5 ± 0.7 vs 1.3 ± 0.5, p = 0.03)] in ACS patients compared to controls. Lower percentages of these fatty acids in HDL were associated with higher odds of developing ACS. Our results suggest that distinct phospholipid fatty acid profiles found in HDL from ACS patients could be one of the contributing factors to the deranged HDL functions in these patients apart from the protein content and the inflammatory conditions.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atherosclerosis; Fatty acids; High-density lipoprotein; Lecithin cholesterol acyl transferase; Phospholipids

Mesh:

Substances:

Year:  2021        PMID: 34843015     DOI: 10.1007/s11010-021-04304-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  56 in total

Review 1.  Antiinflammatory properties of HDL.

Authors:  Philip J Barter; Stephen Nicholls; Kerry-Anne Rye; G M Anantharamaiah; Mohamad Navab; Alan M Fogelman
Journal:  Circ Res       Date:  2004-10-15       Impact factor: 17.367

Review 2.  Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells.

Authors:  Anne Negre-Salvayre; Nicole Dousset; Gianna Ferretti; Tiziana Bacchetti; Giovanna Curatola; Robert Salvayre
Journal:  Free Radic Biol Med       Date:  2006-07-12       Impact factor: 7.376

3.  Is HDL function as important as HDL quantity in the coronary artery disease risk assessment?

Authors:  Sunita Dodani; Deanna G Grice; Sunil Joshi
Journal:  J Clin Lipidol       Date:  2009-02-06       Impact factor: 4.766

Review 4.  HDL and cholesterol: life after the divorce?

Authors:  Kasey C Vickers; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-03-19       Impact factor: 5.922

Review 5.  Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.

Authors:  Amy S Shah; Lirong Tan; Jason Lu Long; W Sean Davidson
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

6.  Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles.

Authors:  Karita Haapasalo; Kok van Kessel; Eija Nissilä; Jari Metso; Tiira Johansson; Sini Miettinen; Markku Varjosalo; Juha Kirveskari; Pentti Kuusela; Angelika Chroni; Matti Jauhiainen; Jos van Strijp; T Sakari Jokiranta
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

Review 7.  HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Alan M Fogelman
Journal:  Nat Rev Cardiol       Date:  2011-02-08       Impact factor: 32.419

8.  The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Authors:  Margarita de la Llera-Moya; Denise Drazul-Schrader; Bela F Asztalos; Marina Cuchel; Daniel J Rader; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-14       Impact factor: 8.311

Review 9.  Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within.

Authors:  Sarina Kajani; Sean Curley; Fiona C McGillicuddy
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

10.  HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.

Authors:  Peter J Meikle; Melissa F Formosa; Natalie A Mellett; Kaushala S Jayawardana; Corey Giles; David A Bertovic; Garry L Jennings; Wayne Childs; Medini Reddy; Andrew L Carey; Arul Baradi; Shane Nanayakkara; Andrew M Wilson; Stephen J Duffy; Bronwyn A Kingwell
Journal:  J Am Heart Assoc       Date:  2019-06-04       Impact factor: 5.501

View more
  1 in total

1.  Non-invasive diagnostic potential of microRNA-203 in liquid biopsy of urothelial carcinoma of bladder.

Authors:  Pradeep Singh; Aishwarya Singh; Nidhi Gupta; K David Raja; Prabhjot Singh; Sarita Agarwal; Alpana Sharma
Journal:  Mol Cell Biochem       Date:  2022-04-20       Impact factor: 3.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.